NCT00002365View on ClinicalTrials.gov

A Study of LXR015-1 in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

LXR015-1

Trial Locations (1)

94705

East Bay AIDS Ctr, Berkeley

Sponsors

Lead Sponsor

LXR Biotechnology
All Listed Sponsors
lead

LXR Biotechnology

INDUSTRY